col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: International Medical Press
  original article Journal Date Title Authors All Authors
1 [GO] Antiviral Therapy 2021―Mar―11 The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: a rapid review Jienchi Dorward, Oghenekome Gbinigie, Ting Cai, Nia W Roberts, Nigel Garrett, Gail Hayward, Christopher C Butler
2 [GO] Antiviral Therapy 2021―Feb―22 COVID-19 and hepatitis B infection Saleh A Alqahtani, Maria Buti
3 [GO] Antiviral Therapy 2021―Jan―18 Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity Mattia Trunfio, Elena Salvador, Alberto Gaviraghi, Sabrina Audagnotto, Letizia Marinaro, Ilaria Motta, et al. (+6)
4 [GO] Antiviral Therapy 2020―Aug―03 Evaluation of drugs for potential repurposing against COVID-19 using a tier-based scoring system Michael A Jarvis, Frederick A Hansen, Kyle Rosenke, Elaine Haddock, Christopher Rollinson, Simon Rule, et al. (+3)
5 [GO] Antiviral Therapy 2020―Jun―26 SARS-CoV-2 and HIV protease inhibitors: why lopinavir/ritonavir will not work for COVID-19 infection Elise J Smolders, Lindsey HM te Brake, David M Burger
6 [GO] Antiviral Therapy 2020―Jun―04 Combination antiviral therapy with lopinavir/ritonavir, arbidol and interferon-α1b for COVID-19Combination antiviral therapy with lopinavir/ritonavir, arbidol and interferon-α1b for COVID-19 Xiangyang Xie, Yuanliang Jiang, Yuan Zeng, Hui Liu


[de][en]

Last change 2021―Sep―04 16:13:39 UTC

© Daten-Quadrat 2021       Done in 0.014 sec